Today MediciNova, Inc. (NASDAQ:MNOV), a biotechnology firm, announced that it had engaged FLG Partners as interim CFO. Company 8-K. FLG Partner: Mike Gennaro.
Recent News

Novartis acquires Kedalion Therapeutics
East Hanover, N.J., June 30, 2022 — Novartis today announced that it has acquired Kedalion Therapeutics and its AcuStream™ technology, an innovative device that may have the potential to facilitate precise dosing and accurate delivery of certain topical ophthalmic medications to the eye. FLG client, Kedalion Therapeutics, is a clinical-stage,…Read More
Read More
Testimonials
“BrightSource is a complex environment for a variety of reasons: innovative technology, differing objectives among investors, global operations, not quite commercial status – among others. Our FLG partner, Doug Lehrmann, stepped in initially to our CFO slot under a “we need you now” scenario. He quickly sized up the situation, became a respected and trusted member of our Executive Committee and provided quick actions along a variety of fronts that streamlined operations and stabilized the Company. I then asked Doug to move to a newly created COO slot so that I could promote a high potential internal resource to CFO; Doug made the move seamlessly and was invaluable to me in taking on specific tasks that crossed multiple functional responsibilities. BrightSource is a now on path that we believe best positions it for success. Without Doug’s help, I’m not sure we would have the opportunity – for sure full of challenges, but a real chance – that we now have in front of us. Thanks for helping getting Doug to us, and we wish him and FLG much success in the future.”
David Ramm, Chairman and CEO, BrightSourceRead More